BRAF and cutaneous melanoma: Surgery and possible adjuvant therapy, with either systemic immunotherapy or targeted therapy, are still considered the treatment of choice in cutaneous melanoma, with good prognosis depending on the stage of the disease, BRAF mutation status, and risk of recurrence [4].